Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Fecal microbiota composition of breast-fed infants is correlated with human milk oligosaccharides consumed. ✅
Go to Publication ✅
Journal of pediatric gastroenterology and nutrition (J Pediatr Gastroenterol Nutr ) Vol: 60 Issue 6 Pages: 825-33 Pub: 2015 Jun Epub: Authors Wang M , Li M , Wu S , Lebrilla CB , Chapkin RS , Ivanov I , Donovan SM , |
|
|
Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 14 Issue 7 Pages: e0219366 Pub: 2019 Epub: 2019 Jul 8 Authors Rogier R , Ederveen THA , Wopereis H , Hartog A , Boekhorst J , van Hijum SAFT , Knol J , Garssen J , Walgreen B , Helsen MM , van der Kraan PM , van Lent PLEM , van de Loo FAJ , Abdollahi-Roodsaz S , Koenders MI , |
|
|
2`-fucosyllactose Supplementation Improves Gut-Brain Signaling and Diet-Induced Obese Phenotype and Changes the Gut Microbiota in High Fat-Fed Mice. ✅
Nutrients (Nutrients ) Vol: 12 Issue 4 Pages: Pub: 2020 Apr 5 Epub: 2020 Apr 5 Authors Lee S , Goodson M , Vang W , Kalanetra K , Barile D , Raybould H , |
|
|
Immunomodulatory and Prebiotic Effects of 2`-Fucosyllactose in Suckling Rats. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 10 Issue Pages: 1773 Pub: 2019 Epub: 2019 Jul 31 Authors Azagra-Boronat I , Massot-Cladera M , Mayneris-Perxachs J , Knipping K , Van`t Land B , Tims S , Stahl B , Garssen J , Franch À , Castell M , Rodríguez-Lagunas MJ , Pérez-Cano FJ , |
|
|
The Protective Effects of 2`-Fucosyllactose against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion. ✅
Nutrients (Nutrients ) Vol: 12 Issue 5 Pages: Pub: 2020 May 1 Epub: 2020 May 1 Authors Wang Y , Zou Y , Wang J , Ma H , Zhang B , Wang S , |
|
|
The Protective Effects of 2`-Fucosyllactose against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion. ✅
Nutrients (Nutrients ) Vol: 12 Issue 5 Pages: Pub: 2020 May 1 Epub: 2020 May 1 Authors Wang Y , Zou Y , Wang J , Ma H , Zhang B , Wang S , |
|
|
The Protective Effects of 2`-Fucosyllactose against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion. ✅
Nutrients (Nutrients ) Vol: 12 Issue 5 Pages: Pub: 2020 May 1 Epub: 2020 May 1 Authors Wang Y , Zou Y , Wang J , Ma H , Zhang B , Wang S , |
|
|
2'-Fucosyllactose alleviates OVA-induced food allergy in mice by ameliorating intestinal microecology and regulating the imbalance of Th2/Th1 proportion. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 24 Pages: 10924-10940 Pub: 2023 Dec 11 Epub: 2023 Dec 11 Authors Kou R , Wang J , Li A , Wang Y , Fan D , Zhang B , Fu W , Liu J , Fu H , Wang S , |
|
|
2'-Fucosyllactose alleviates OVA-induced food allergy in mice by ameliorating intestinal microecology and regulating the imbalance of Th2/Th1 proportion. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 24 Pages: 10924-10940 Pub: 2023 Dec 11 Epub: 2023 Dec 11 Authors Kou R , Wang J , Li A , Wang Y , Fan D , Zhang B , Fu W , Liu J , Fu H , Wang S , |
|
|
Butyrate producing colonic Clostridiales metabolise human milk oligosaccharides and cross feed on mucin via conserved pathways. ✅
Go to Publication ✅
Nature communications (Nat Commun ) Vol: 11 Issue 1 Pages: 3285 Pub: 2020 Jul 3 Epub: 2020 Jul 3 Authors Pichler MJ , Yamada C , Shuoker B , Alvarez-Silva C , Gotoh A , Leth ML , Schoof E , Katoh T , Sakanaka M , Katayama T , Jin C , Karlsson NG , Arumugam M , Fushinobu S , Abou Hachem M , |
|
|
Human milk oligosaccharides 2'-fucosyllactose and 3-fucosyllactose attenuate ovalbumin-induced food allergy through immunoregulation and gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 16 Issue 4 Pages: 1267-1283 Pub: 2025 Feb 17 Epub: 2025 Feb 17 Authors Wu S , Chen H , Yu R , Li H , Zhao J , Stanton C , Paul Ross R , Chen W , Yang B , |
|
|
High doses of the galactooligosaccharides, 2'-fucosyllactose alleviate immunodeficiency in vitro and in vivo. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: 64 Issue 5 Pages: 215 Pub: 2025 Jun 9 Epub: 2025 Jun 9 Authors Li X , Li Y , Cheng K , Song T , Wang Y , Zhou H , Xu Y , Chaibou OZ , Wang B , Li H , |
|
|
High doses of the galactooligosaccharides, 2'-fucosyllactose alleviate immunodeficiency in vitro and in vivo. ✅
Go to Publication ✅
European journal of nutrition (Eur J Nutr ) Vol: 64 Issue 5 Pages: 215 Pub: 2025 Jun 9 Epub: 2025 Jun 9 Authors Li X , Li Y , Cheng K , Song T , Wang Y , Zhou H , Xu Y , Chaibou OZ , Wang B , Li H , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
